Non-alcoholic fatty liver disease ultrasound: Difference between revisions
Aditya Ganti (talk | contribs) No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
[[Ultrasound]] may be helpful in the diagnosis of | [[Ultrasound]] may be helpful in the diagnosis of non-alcoholic fatty liver disease. [[Ultrasound]] is often considered as the first line of imaging choice to diagnose non-alcoholic fatty liver disease. Moderate to high amount of fatty infiltration of liver is the most prominent and diagnostic finding on an ultrasound in patients diagnosed non-alcoholic fatty liver disease. | ||
==Ultrasound== | ==Ultrasound== | ||
*Ultrasound | *Ultrasound is considered as the first line of imaging choice for NAFLD patients <ref name="urlNonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician">{{cite web |url=http://www.aafp.org/afp/2013/0701/p35.html |title=Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician |format= |work= |accessdate=}}</ref><ref name="urlNonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician2">{{cite web |url=http://www.aafp.org/afp/2013/0701/p35.html |title=Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician |format= |work= |accessdate=}}</ref> | ||
*Ultrasound have senstivity of 60-100 and | *Ultrasound have senstivity of 60-100 and 80-100 % of positive predictive value. | ||
*Findings on an ultrasound suggestive of NAFLD include: | *Findings on an ultrasound suggestive of NAFLD include: | ||
** | **Moderate to high amount of fatty infiltration of liver. | ||
** | **Rarely moderate-to-severe degree hepatic steatosis. <ref name="pmid28994271">{{cite journal |vauthors=Lee DH |title=Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification |journal=Clin Mol Hepatol |volume= |issue= |pages= |year=2017 |pmid=28994271 |doi=10.3350/cmh.2017.0042 |url=}}</ref> | ||
* | *Ultrasound elastography is another kind of ultrasound that can give [[qualitative]] progression of the liver fibrosis. | ||
*The only limitation of using an ultrasound is that it cannot differentiate between [[hepatic fibrosis]] and [[steatosis]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 16:57, 22 December 2017
Non-Alcoholic Fatty Liver Disease Microchapters |
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case studies |
Non-alcoholic fatty liver disease ultrasound On the Web |
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease ultrasound |
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
Risk calculators and risk factors for Non-alcoholic fatty liver disease ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
Ultrasound may be helpful in the diagnosis of non-alcoholic fatty liver disease. Ultrasound is often considered as the first line of imaging choice to diagnose non-alcoholic fatty liver disease. Moderate to high amount of fatty infiltration of liver is the most prominent and diagnostic finding on an ultrasound in patients diagnosed non-alcoholic fatty liver disease.
Ultrasound
- Ultrasound is considered as the first line of imaging choice for NAFLD patients [1][2]
- Ultrasound have senstivity of 60-100 and 80-100 % of positive predictive value.
- Findings on an ultrasound suggestive of NAFLD include:
- Moderate to high amount of fatty infiltration of liver.
- Rarely moderate-to-severe degree hepatic steatosis. [3]
- Ultrasound elastography is another kind of ultrasound that can give qualitative progression of the liver fibrosis.
- The only limitation of using an ultrasound is that it cannot differentiate between hepatic fibrosis and steatosis.
References
- ↑ "Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician".
- ↑ "Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician".
- ↑ Lee DH (2017). "Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification". Clin Mol Hepatol. doi:10.3350/cmh.2017.0042. PMID 28994271.